Instituto Brasileiro de Controle do Câncer

Recent papers from Instituto Brasileiro de Controle do Câncer

1. Concentration‐Based Short‐Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 TrialJournal of Surgical Oncology · 2026
2. The importance of incidental coronary artery calcification seen on breast radiation therapy planning scans in women after 60 years oldEuropean Heart Journal · 2026
3. Pembrolizumab plus chemotherapy as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: 4.5-year follow-up from the randomized phase III KEYNOTE-859 studyESMO Open · 2026
4. Sociodemographic and Clinicopathologic Characteristics of Patients With Invasive Breast Cancer in Latin America: The LATINA Breast Cohort (LACOG 0615/MO39485)JCO Global Oncology · 2026
5. Challenges of implementing plasma cfDNA HPV testing in resource limited settings for locally advanced cervical cancerScientific Reports · 2026
6. Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trialInternational Journal of Gynecological Cancer · 2026
7. Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancerEuropean Journal of Cancer · 2026
8. Knowledge, attitudes, and factors influencing clinical trial participation among breast cancer patients in Brazil: The LACOG 1123 (ASTRAL) study.Journal of Clinical Oncology · 2026
9. Immune-related adverse events with immune checkpoint inhibitors: Insights from real-world practice in Brazil.Journal of Clinical Oncology · 2026
10. Trust, ethics, and patient engagement in clinical research: Findings from the LACOG 1123 ASTRAL survey in Brazil.Journal of Clinical Oncology · 2026
11. Pre-Analytical and Analytical Challenges in Whole-Exome Sequencing of Formalin-Fixed Paraffin-Embedded Breast and Prostate Cancer Tissue: A Real-World Multicenter StudyDiagnostics · 2026
12. Time until Oncologic Treatment Approval in Brazil Compared to Europe and the United StatesBrazilian Journal of Oncology · 2026
13. Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trialnpj Breast Cancer · 2026
14. Outcomes of Allogeneic Hematopoietic Cell Transplantation for Hypoplastic Myelodysplastic Syndrome: A Latin American Multicenter AnalysisBiology of Blood and Marrow Transplantation · 2026
15. Understanding Barriers to Clinical Trial Participation Among Cancer Patients: Insights from a Brazilian Oncology CenterBrazilian Journal of Oncology · 2026
16. Identification and Characterization of Perampanel Degradation Products: Stability-Indicating HPLC and In Silico Toxicological AssessmentACS Omega · 2026
17. Recommendations for the treatment of endometrial cancer in settings with limited resources: report from the International Gynecological Cancer Society consensus meetingFrontiers in Oncology · 2026
18. Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancerSHILAP Revista de lepidopterología · 2026
19. Final overall survival results from the EORTC 1333/PEACE-3 trial: Enzalutamide with or without radium-223 in metastatic castration-resistant prostate cancer.Journal of Clinical Oncology · 2026
20. Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancerAnnals of Oncology · 2026